Biotech Values

[vinmantoo]

Jbog,

Definitely a nice premium for FTSV. I don't own as much FTSV as I do TRIL, but it will be a nice chunk of change. I was going to ask when the deal would be finalize but saw it was expected by sometime in the second quarter.

TRIL is already is getting yet another boost from FTSV but is coming off the highs earlier today. I don't think there will be much more upswing for TRIL until the phase I dosage escalation data comes in mid 2020 but who knows.

Could you provide some insight into IOVA you just mentioned?